发明公开
EP1917041A2 USE OF FRUCTOSE-BASED THERAPIES FOR THE TREATMENT OF CANCER 审中-公开
果糖使用基于疗法治疗癌症

  • 专利标题: USE OF FRUCTOSE-BASED THERAPIES FOR THE TREATMENT OF CANCER
  • 专利标题(中): 果糖使用基于疗法治疗癌症
  • 申请号: EP06824852.5
    申请日: 2006-08-24
  • 公开(公告)号: EP1917041A2
    公开(公告)日: 2008-05-07
  • 发明人: HEANEY, Anthony, P.HUI, Hongxiang
  • 申请人: Cedars-Sinai Medical Center
  • 申请人地址: 8700 Beverly Boulevard Los Angeles, California 90048-1869 US
  • 专利权人: Cedars-Sinai Medical Center
  • 当前专利权人: Cedars-Sinai Medical Center
  • 当前专利权人地址: 8700 Beverly Boulevard Los Angeles, California 90048-1869 US
  • 代理机构: Hutter, Anton
  • 优先权: US710762P 20050824; US715514P 20050909
  • 国际公布: WO2007025238 20070301
  • 主分类号: A61K48/00
  • IPC分类号: A61K48/00
USE OF FRUCTOSE-BASED THERAPIES FOR THE TREATMENT OF CANCER
摘要:
The methods and compositions of the invention are based on the preferential utilization of fructose by cancer cells. This invention relates to compositions, methods and kits utilizing fructose and other monosaccharides for the treatment of cancer. This invention also relates to methods and kits for using compositions to mimic or corrupt metabolic pathways of fructose and/or signal transduction pathways related to cancer cells for the treatment of cancer.
信息查询
0/0